Evidence map›Paper›PMID 34064904›Full record

ArticleViruses2021

Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics.

Jorge González-Puelma, Jacqueline Aldridge, Marco Montes de Oca, Mónica Pinto, Roberto Uribe-Paredes, José Fernández-Goycoolea, Diego Alvarez-Saravia, Hermy Álvarez, Gonzalo Encina, Thomas Weitzel and 4 more

3 registry-linked trialsAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05855382 completednot on this mapstarted 2023, after this paper: background citation

A Prevalence Study of Persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region

Typeobservational_patient_registrySponsorUniversidad de MagallanesRan2023 to 2025Enrolled282ConditionsCOVID-19ArmsPersistent COVID-19
NCT05932797 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluation and implementation of a multimodal intervention to reduce symptoms of long covid/prolonged covid in the adult population of punta arenas, chile.

TypeinterventionalSponsorUniversidad de MagallanesRan2023 to 2024Enrolled60ConditionsLong COVID-19 SyndromeArmsMultimodal intervention in Long Covid19
NCT07367867 completednot on this mapstarted 2023, after this paper: background citation

Inflammation in HIV/AIDS-InflammAIDS: an Observational Multicenter Cohort Study Protocol

Typeobservational_patient_registrySponsorUniversidad de MagallanesRan2023 to 2025Enrolled320ConditionsHIV, Metabolic Syndrome, Molecular Biology, Flow Cytometry
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jorge González-PuelmaEscuela de Medicina, Universidad de Magallanes, Punta Arenas 6210427, Chile.
Jacqueline AldridgeDepartamento de Ingeniería en Computación, Universidad de Magallanes, Punta Arenas 6210427, Chile.ORCID 0000-0003-3491-6589
Marco Montes de OcaDepartamento de Ingeniería en Computación, Universidad de Magallanes, Punta Arenas 6210427, Chile.ORCID 0000-0002-3333-4977
Mónica PintoEscuela de Medicina, Universidad de Magallanes, Punta Arenas 6210427, Chile.
Roberto Uribe-ParedesDepartamento de Ingeniería en Computación, Universidad de Magallanes, Punta Arenas 6210427, Chile.ORCID 0000-0001-9519-8862
José Fernández-GoycooleaDepartamento de Matemática y Física, Universidad de Magallanes, Punta Arenas 6210427, Chile.ORCID 0000-0001-5349-4348
Diego Alvarez-SaraviaEscuela de Medicina, Universidad de Magallanes, Punta Arenas 6210427, Chile.ORCID 0000-0003-0753-274X
Hermy ÁlvarezEscuela de Medicina, Universidad de Magallanes, Punta Arenas 6210427, Chile.
Gonzalo EncinaCentro de Genética y Genómica, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7610658, Chile.
Thomas WeitzelLaboratorio Clínico, Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7610658, Chile.ORCID 0000-0002-9804-2123
Rodrigo MuñozEscuela de Medicina, Universidad de Magallanes, Punta Arenas 6210427, Chile.
Álvaro Olivera-NappaCentre for Biotechnology and Bioengineering, Universidad de Chile, Santiago 8370456, Chile.ORCID 0000-0001-6053-7019
Sergio PantanoBiomolecular Simulations Group, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.ORCID 0000-0001-6435-4543
Marcelo A NavarreteEscuela de Medicina, Universidad de Magallanes, Punta Arenas 6210427, Chile.ORCID 0000-0002-2044-9548

Funding

ANID, Chile Fondecyt 1180882
6 · The paper itself

Abstract

The emergence of SARS-CoV-2 variants, as observed with the D614G spike protein mutant and, more recently, with B.1.1.7 (501Y.V1), B.1.351 (501Y.V2) and B.1.1.28.1 (P.1) lineages, represent a continuous threat and might lead to strains of higher infectivity and/or virulence. We report on the occurrence of a SARS-CoV-2 haplotype with nine mutations including D614G/T307I double-mutation of the spike. This variant expanded and completely replaced previous lineages within a short period in the subantarctic Magallanes Region, southern Chile. The rapid lineage shift was accompanied by a significant increase of cases, resulting in one of the highest incidence rates worldwide. Comparative coarse-grained molecular dynamic simulations indicated that T307I and D614G belong to a previously unrecognized dynamic domain, interfering with the mobility of the receptor binding domain of the spike. The T307I mutation showed a synergistic effect with the D614G. Continuous surveillance of new mutations and molecular analyses of such variations are important tools to understand the molecular mechanisms defining infectivity and virulence of current and future SARS-CoV-2 strains.

Indexed as

Antarctic RegionsAntibodies, NeutralizingAntibodies, ViralChileCOVID-19HaplotypesHumansMutant ProteinsMutationProtein BindingSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralMutant ProteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Covid19SARS-CoV2variant

Identifiers

PMID34064904
PMCPMC8151058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.